Using an in vivo mouse model, scientists revealed that ASC-exosomes could ameliorate AD symptoms through, i.e., reducing mRNA expression of various inflammatory cytokines, such as interleukin (IL)-4, IL-23, IL-31 and tumor necrosis factor-α (TNF-α). The gene discussed is TNF; the disease is Alzheimer disease.